The U.S. Food and Drug Administration (FDA) approves a third over-the-counter option for reversing opioid overdoses. In an announcement Tuesday, the FDA says it has approved a 4-milligram intranasal naloxone hydrochloride nasal spray, Rextovy, for emergency treatment of opioid overdose. The product joins other nonprescription naloxone options previously approved for OTC use. The FDA states that the availability of OTC naloxone is intended to help people quickly access overdose reversal without needing a prescription. The agency says consumers will be able to purchase the spray directly in retail settings such as pharmacies and convenience stores, as well as online. The FDA also describes the approval as a measure that can save lives and reduce costs. All sources characterize the action as an FDA expansion of public access to naloxone by adding another OTC intranasal formulation for use in suspected opioid overdose emergencies.
FDA approves third over-the-counter naloxone nasal spray for opioid overdose
The U.S. Food and Drug Administration (FDA) approves a third over-the-counter option for reversing opioid overdoses. In an announcement Tuesday, the FDA says it has approved a 4-milligram intranasal n...
- The FDA approves a new over-the-counter naloxone nasal spray, Rextovy.
- Rextovy contains 4 mg of naloxone hydrochloride and is administered intranasally.
- The FDA describes it as an option for the emergency treatment of opioid overdose.
- The FDA says consumers can buy it directly without a prescription via pharmacies, convenience stores, and online.
- The approval adds a third OTC naloxone nasal spray to existing OTC options.
The Food and Drug Administration (FDA) approved a third over-the-counter version of naloxone nasal spray Tuesday, in a move the agency said could save lives and reduce costs. The agency approved another Rextovy, a 4 milligram naloxone nasal spray for the emergency treatment of opioid overdose. FDA said consumers may directly buy it in pharmacies, convenience stores and online. Naloxone is a...
8 hours ago(MedPage Today) -- The FDA approved another opioid overdose reversal product for over-the-counter (OTC) use, the agency announced on Tuesday. The 4-mg intranasal naloxone hydrochloride (Rextovy) nasal spray joins other similar nonprescription...
11 hours ago
Pauline Hanson brands climate change a “hoax” in National Press Club speech
One Nation leader Pauline Hanson says global warming and climate change are a “hoax” during a speech to the National Pre...
UN Secretary-General visits Haiti amid surging gang violence and displacement
U.N. Secretary-General António Guterres visits Haiti as the country faces a deepening humanitarian crisis driven by gang...
NASA names Italian astronaut Luca Parmitano pilot for Artemis III test mission
NASA selects Italian astronaut Luca Parmitano to serve as pilot for Artemis III, a near-Earth test flight expected to la...